Trial · NCT03467932
Adverse events495
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 495
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anemia | Blood and lymphatic system disorders | Combined Cohort A + Cohort B: Matched Placebo | 0 | 82 | 0 |
| other | Anemia | Blood and lymphatic system disorders | Cohort A: ORMD-0801 Once Daily - QD | 3 | 69 | 3 |
| other | Anemia | Blood and lymphatic system disorders | Cohort A: ORMD-0801 Twice Daily - BID | 1 | 68 | 1 |
| other | Anemia | Blood and lymphatic system disorders | Cohort A: ORMD-0801 Three Times Daily - TID | 0 | 69 | 0 |
| other | Anemia | Blood and lymphatic system disorders | Cohort B:ORMD-0801, 8 mg Once Daily - QD | 0 | 15 | 0 |
| other | Anemia | Blood and lymphatic system disorders | Cohort B: ORMD-0801 8 mg Twice Daily - BID | 1 | 17 | 1 |
| other | Anemia | Blood and lymphatic system disorders | Cohort B: ORMD-0801 16 mg Once Daily - QD | 1 | 18 | 1 |
| other | Anemia | Blood and lymphatic system disorders | Cohort B: ORMD-0801 16 mg Twice Daily - BID | 0 | 15 | 0 |
| other | Anemia | Blood and lymphatic system disorders | Excipient Matched Placebo -TID | 0 | 20 | 0 |
| other | Angina Pectoris | Cardiac disorders | Combined Cohort A + Cohort B: Matched Placebo | 0 | 82 | 0 |
| other | Angina Pectoris | Cardiac disorders | Cohort A: ORMD-0801 Once Daily - QD | 1 | 69 | 1 |
| other | Angina Pectoris | Cardiac disorders | Cohort A: ORMD-0801 Twice Daily - BID | 0 | 68 | 0 |
| other | Angina Pectoris | Cardiac disorders | Cohort A: ORMD-0801 Three Times Daily - TID | 0 | 69 | 0 |
| other | Angina Pectoris | Cardiac disorders | Cohort B:ORMD-0801, 8 mg Once Daily - QD | 0 | 15 | 0 |
| other | Angina Pectoris | Cardiac disorders | Cohort B: ORMD-0801 8 mg Twice Daily - BID | 0 | 17 | 0 |
| other | Angina Pectoris | Cardiac disorders | Cohort B: ORMD-0801 16 mg Once Daily - QD | 0 | 18 | 0 |
| other | Angina Pectoris | Cardiac disorders | Cohort B: ORMD-0801 16 mg Twice Daily - BID | 0 | 15 | 0 |
| other | Angina Pectoris | Cardiac disorders | Excipient Matched Placebo -TID | 0 | 20 | 0 |
| other | Atrial Fibrillation | Cardiac disorders | Combined Cohort A + Cohort B: Matched Placebo | 0 | 82 | 0 |
| other | Atrial Fibrillation | Cardiac disorders | Cohort A: ORMD-0801 Once Daily - QD | 3 | 69 | 3 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03467932/events